Mechanisms And Prognosis of Stroke-Heart Syndrome
NCT06954103
Acute Coronary Syndrome, Acute Coronary Syndromes
Wuhan, Hubei, China
View Trial DetailsNCT Number: NCT07675434
Suspected acute or subacute cardiovascular diseases-including chest pain, dyspnea, and palpitations-are among the most common reasons for unscheduled emergency department visits and pre-hospital referrals. Despite this high clinical burden, the diagnostic yield is often limited, with a frequent mismatch between initial clinical suspicion and final diagnosis, contributing to substantial healthcare utilization and hospitalization rates. Current evidence is largely focused on specific conditions such as acute coronary syndromes, heart failure, arrhythmias, or pulmonary embolism, and rarely integrates the full spectrum of clinical, biological, and imaging data obtained during initial evaluation.
To address this gap, we will establish a prospective cohort of all consecutive patients referred to the ambulatory day-hospital cardiology unit at Lariboisière University Hospital. This unit acts as a specialized downstream referral structure within the emergency care pathway, receiving patients after triage by emergency physicians, pre-hospital regulation services (SAMU), mobile intensive care units (SMUR), or emergency departments. Although it does not capture all suspected cardiovascular emergencies, it represents a selected real-world population deemed to require specialized acute cardiology assessment.
The primary objective is to assess the frequency of cardiac conditions diagnosed in this cohort. Secondary objectives include characterization of patient profiles and diagnostic pathways; evaluation of the diagnostic and prognostic performance of clinical, biological, imaging, and multimodal parameters using final Heart Team diagnosis as reference; analysis of prior health history and healthcare utilization; and assessment of the medico-economic burden of suspected acute cardiovascular disease. The study will further support the development of a dedicated biobank and the validation of next-generation biomarkers, including AI-driven and voice-based markers, as well as decision-support algorithms for binary classification of cardiac involvement. Through integration of multimodal data and linkage with national health records, this approach aims to improve diagnostic accuracy, risk stratification, and understanding of the healthcare impact of acute cardiovascular presentations in a real-world setting.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to five years of follow-up.
Time frame: From enrollement to ten years of follow-up.
The occurrence of:
n. Electrophysiological studies (catheter ablation, pacemaker / defibrillator implantation...)
Time frame: From enrollement to five years of follow-up.
Cost-effectiveness of the CESAR care pathway compared with a propensity score-matched control population extracted from the French national health claims database.
Time frame: From enrollement to six months of follow-up.
Time frame: At enrollement (D0).
The occurrence of: a. All-cause mortality b. Cardiovascular mortality c. Sudden cardiac death d. Hospitalization for any cardiovascular reason and duration of hospitalization
Time frame: From enrollement to five years of follow-up.
Time frame: From enrollement to five years of follow-up.
Event-free survival in patients managed through the CESAR care pathway compared with a propensity score-matched control population extracted from the French national health claims database.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to six months of follow-up.
Time frame: From enrollement to five years of follow-up.
Cumulative duration of sick leave during follow-up in days.
Contact information is provided by the study sponsor or research team.
Julien HUDELO, MD
CONTACT
Théo PEZEL, MD, PhD
CONTACT
Assistance Publique - Hôpitaux de Paris
Other
CESAR Study: Prospective Cohort of Consecutive Patients Undergoing Cardiologic Evaluation in a Specialized Ambulatory Referral Unit
Acronym: CESAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06954103
Acute Coronary Syndrome, Acute Coronary Syndromes
Wuhan, Hubei, China
View Trial DetailsNCT06903754
Acute Coronary Syndrome, Acute Coronary Syndromes
OUDA, Morocco
View Trial DetailsNCT06691477
Acute Coronary Syndrome, Acute Coronary Syndromes
Guangzhou, China
View Trial DetailsNCT01370278
Acute Coronary Syndrome, Acute Coronary Syndromes
Houston, Texas, United States
View Trial Details